AI application in pathology reveals novel insights in endometrial cancer diagnostics

byLeiden Universityim4MEC deep learning pipeline. (A) Whole-slide images were segmented and cut into non-overlapping square tiles of 360 μm at 40× magnification and resized to 224 × 224 pixels.

Updated on: January 02,2024

AI application in pathology reveals novel insights in endometrial cancer diagnostics

byLeiden Universityim4MEC deep learning pipeline. (A) Whole-slide images were segmented and cut into non-overlapping square tiles of 360 μm at 40× magnification and resized to 224 × 224 pixels.

Updated on:January 02,2024

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl

Updated on: March 30,2024

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl

Updated on:March 30,2024

Drug-like molecules show early success in targeting breast cancer brain metastases

byDrexel UniversityComputational pipeline and predicted drug-like properties for the discovery of AD-2441 and its analogs. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.

Updated on: August 01,2024

Drug-like molecules show early success in targeting breast cancer brain metastases

byDrexel UniversityComputational pipeline and predicted drug-like properties for the discovery of AD-2441 and its analogs. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.

Updated on:August 01,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on: March 05,2024

Lab-grown tumors predict treatment outcomes in landmark study

by Walter and Eliza Hall InstituteA 3D structure of an organoid formed from human bowel cancer cells. Blue marks the nucleus of the individual cell, green is a protein that sticks each cell toget

Updated on:March 05,2024

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg

Updated on: June 08,2024

Researchers take aim at circadian clock in deadly brain cancer

by University of Southern CaliforniaA microscope image of brain cancer cells, a glioma tumor type known as anaplastic astrocytoma. Credit: Wikimedia/ CC BY-SA 3.0Scientists at USC and UC San Dieg

Updated on:June 08,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on: January 22,2024

Study sends strong signal not to sequence immune checkpoint inhibitors in advanced kidney cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPatients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment. The CONTACT-0

Updated on:January 22,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Updated on: February 23,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Updated on:February 23,2024

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on: April 10,2024

Patient cost responsibility up for guideline-discordant care

(HealthDay)—For patients with metastatic breast cancer (MBC), receipt of National Comprehensive Cancer Network Guideline-discordant care is associated with higher patient cost responsibility, accordin

Updated on:April 10,2024

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth

Updated on: May 23,2024

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth

Updated on:May 23,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on: February 23,2024

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Updated on:February 23,2024

Invention makes biopsies less invasive and more informative

by National University of SingaporeThe new STAMP technology developed by Assistant Professor Shao Huilin (left), doctoral student Mr Noah Sundah (right) and their team from NUS Institute for Heal

Updated on: April 18,2024

Invention makes biopsies less invasive and more informative

by National University of SingaporeThe new STAMP technology developed by Assistant Professor Shao Huilin (left), doctoral student Mr Noah Sundah (right) and their team from NUS Institute for Heal

Updated on:April 18,2024